| Date Filed | Type | Description |
| 10/04/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 9,523 options to buy
@ $1.26, valued at
$12k
|
|
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,654 options to buy
@ $3.42, valued at
$12.5k
|
|
| 06/12/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 04/05/2023 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,451 options to buy
@ $4.25, valued at
$14.7k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 10,416 options to buy
@ $6.44, valued at
$67.1k
|
|
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2019 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.31, valued at
$107.8k
|
|
| 06/10/2019 |
4
| Hege Kristen (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $7.99, valued at
$279.7k
|
|
| 10/22/2018 |
4
| Hege Kristen (Director) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $11.79, valued at
$412.7k
|
|
| 10/22/2018 |
3
| Hege Kristen (Director) has filed a Form 3 on Arcus Biosciences, Inc. |
| 09/21/2018 |
4
| Hege Kristen (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.27, valued at
$122.7k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2017 |
3
| Hege Kristen (Director) has filed a Form 3 on Mersana Therapeutics, Inc. |